Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-03

FDA Approved: ESLICARBAZEPINE ACETATE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' eslicarbazepine acetate as a generic, original-application product for adjunctive treatment of partial-onset seizures in ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

ORIG AP for ESLICARBAZEPINE ACETATE (ESLICARBAZEPINE ACETATE)